Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled multicenter trial of Guizhi Tangju Granules for diabetic foot ulcer healing
CTR20201182Phase 2Active
- Sponsor
- Tangning Pharmaceutical Technology
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Guizhi Tangju in diabetic foot ulcer (DFU), sponsored by Tangning Pharmaceutical Technology. Started Jul 2020; status: active.
02
Drugs
Guizhi Tangju
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on CTR20201182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201182.